Page 4 - Breaking Science News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BOSTON — In patients with postinfarction ventricular septal defects, percutaneous and surgical treatments reduced mortality rates compared with historical medical therapy data, researchers reported at TCT 2022.The percutaneous and surgical strategies for postinfarction ventricular septal defects (VSD) did not differ significantly from each other in all-cause mortality at 5 years, but the

NEW YORK, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory...

Elucid Presents Results of the EVAPORATE Study at ESC Preventive Cardiology 2021 Late Breakers Elucid Software Quantifies Plaque Morphology to Enable Better Assessment of IPE Treatment Effects Elucid, a medical technology company developing AI software for physicians to optimize the treatment of patients with known or suspected vascular disease, announced that first author and Elucid founder Andrew Buckler presented findings today from the EVAPORATE (Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy, ClinicalTrials.gov Identifi...